Promoter holding
64.27%
LD
Lucid Diagnostics (Karnataka) Private Limited - Due diligence report
A 360° intelligence report on Luciddiagnostics: trust score, financial health, credit view, compliance, directors, growth and distress signa…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Luciddiagnostics — 360° Intelligence Report
Generated from MCA filings & public records48/100
Trust Score
Caution Indicated
Luciddiagnostics is assessed as Caution Indicated with a Trust Score of 48/100. Luciddiagnostics is an active private limited indian non-government company incorporated in 2011, operating in the Healthcare sector. Reported revenue has declined across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and high financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Lucid Diagnostics (Karnataka) Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreCaution Indicated
48/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
45/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
5/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreCaution Indicated
40/100
Revenue, profit, asset and hiring momentum.
Distress ScoreCaution Indicated
30/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
Charges position: 2 open (96.50 Lakh) · 5 satisfied (13.07 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Ge Capital Services India | 3 | 48.0 cr |
| Union Bank Of India | 1 | 48.0 cr |
| Others | 2 | 48.0 cr |
| Axis Bank Limited | 1 | 48.0 cr |
Compliance Score: 45/100 Caution Indicated
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2020 - filings overdue.
- Flagged by authority: EPFO.
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SAI BALAJI DESI REDDY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRASANNA VINAY VENKATESH NYAPATHI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| CHAKRAVARTHI SRINIVAS GUTTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2020 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Lucid Medical Diagnostics Private Limited
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Lucid Medical Diagnostics Private Limited | Holding Company | 74.00% |
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 40 · Distress 30
Growth signals & trust indicators
Operating for 14+ years.
Active EPFO - real payroll on record.
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
Negative net worth.
Statutory filings appear overdue.
Compliance score is weak (45/100).
2 open charge(s) registered - assets are encumbered.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence41/100
Caution indicated
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 4 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment31/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 2 open charge(s) of 96.50 Lakh already registered.
- Compliance gaps should be priced into terms.
Investor view30/100
Limited indicators at present
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events20 Jun 2022
Charge satisfied
Others
31 Dec 2020
Last AGM held
Annual general meeting
31 Mar 2020
Latest balance sheet
Filed with ROC
25 Oct 2019
Charge created
Axis Bank Limited - 46.50 Lakh
24 May 2018
Charge satisfied
Ge Capital Services India
08 May 2018
Charge satisfied
Ge Capital Services India
31 Mar 2018
Charge created
Others - 1.40 cr
25 Jan 2017
Charge created
Others - 50.00 Lakh
16 Jul 2016
Charge satisfied
Union Bank Of India
04 Jan 2016
Director ceased
SUNITHA LINGAREDDY
29 Sep 2015
Director ceased
PRASANNA VINAY VENKATESH NYAPATHI
08 Jan 2015
Director appointed
PRASANNA VINAY VENKATESH NYAPATHI (Director)
05 Dec 2014
Director appointed
SAI BALAJI DESI REDDY (Director)
31 Mar 2013
Securities allotted
1420000 Equity Shares Without Differential Rights - 1.42 cr raised
26 Mar 2013
Securities allotted
2015340 Equity Shares Without Differential Rights - 2.02 cr raised
10
Key Observations
Auto-generated from the data aboveRevenue declined 38% over the last 4 financial year(s).
Net profit margin moved from 1.42 to 2.1x.
3 active director(s) / partner(s); board looks stable and experienced.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2020 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Vaishno Pharmatek Private Limited | U74999TG2018PTC123033 | Hyderabad, Telangana, India |
| Ms Genomic Clinicals Private Limited | U74999TG2018PTC124270 | Hyderabad, Telangana, India |
| Chowgule Mediconsult Private Limited | U85199GA2000PTC002892 | Goa, Goa, India |
| Tervigon Collective Private Limited | U85100DL2013PTC256194 | New Delhi, Delhi, India |
| Mmg | U74999MH2017FTC291405 | Mumbai, Maharashtra, India |
| Cicerone Technologies Private Limited | U93000HR2015PTC055574 | Gurugram, Haryana, India |
| Martha Healthcare Services Private Limited | U74900AP2016PTC098376 | Nawabpet, Andhra Pradesh, India |
| Harrissa Healthcare Private Limited | U74900RJ2015PTC048775 | Jaipur, Rajasthan, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Luciddiagnostics before audits and certifications: compliance score 45/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Luciddiagnostics: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Limited indicators at present. Growth score 40/100, margin trends, ownership structure and peer set for Luciddiagnostics - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Caution indicated. Trust score 48/100, distress signals and MSME payment-delay disclosures - know whether Luciddiagnostics pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Luciddiagnostics - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Luciddiagnostics an active company?
Luciddiagnostics has MCA status “Active” with a compliance score of 45/100 (Caution Indicated).
Is Luciddiagnostics financially healthy?
Luciddiagnostics has a Financial Health Score of 5/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Luciddiagnostics?
Its overall Trust Score is 48/100 (Caution Indicated). Vendor verdict: Caution indicated. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Luciddiagnostics?
The ultimate holding entity is Lucid Medical Diagnostics Private Limited. 3 active director(s) are on record.
Does Luciddiagnostics have loans or charges against its assets?
2 open charge(s) are registered against its assets, and 5 earlier charge(s) stand satisfied.
Is Luciddiagnostics up to date with its ROC filings?
Last balance sheet is for Mar 2020 - filings overdue. Overall compliance score: 45/100 (Caution Indicated).
Is it risky to lend to Luciddiagnostics?
Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
